Cargando…
Development of Small-Molecule Inhibitors Against Zika Virus Infection
In recent years, the outbreak of infectious disease caused by Zika virus (ZIKV) has posed a major threat to global public health, calling for the development of therapeutics to treat ZIKV disease. Here, we have described the different stages of the ZIKV life cycle and summarized the latest progress...
Autores principales: | Wang, Lili, Liang, Ruiying, Gao, Yaning, Li, Yanbai, Deng, Xiaoqian, Xiang, Rong, Zhang, Yina, Ying, Tianlei, Jiang, Shibo, Yu, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909824/ https://www.ncbi.nlm.nih.gov/pubmed/31866959 http://dx.doi.org/10.3389/fmicb.2019.02725 |
Ejemplares similares
-
Recent advances in developing small-molecule inhibitors against SARS-CoV-2
por: Xiang, Rong, et al.
Publicado: (2022) -
Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
por: Yu, Fei, et al.
Publicado: (2020) -
Development of Small-Molecule MERS-CoV Inhibitors
por: Liang, Ruiying, et al.
Publicado: (2018) -
Influenza virus glycoprotein-reactive human monoclonal antibodies
por: Li, Yanbai, et al.
Publicado: (2020) -
Advancement in the Development of Therapeutics Against Zika Virus Infection
por: Li, Kangchen, et al.
Publicado: (2022)